Solid-state structures of cis- and trans-1-cyclohexyl-2-phenyl-3-(p-toluyl)aziridines

Solid-state structures have been determined for cis- and trans-1-cyclohexyl-2-phenyl-3-(p-toluyl)aziridines using single-crystal X-ray diffraction techniques. The cis isomer crystallizes in the centrosymmetric monoclinic space group P2₁/c (No. 14), with a = 18.669(3)Å, b = 5.709(1)Å, c = 17.412(2)Å, β = 96.29(1)° and Z = 4; the trans isomer crystallizes in the noncentrosymmetric orthorhombic space group Pna2₁ (No. 33), with a = 17.089(2)Å, b = 18.729(3)Å, c = 5.749(1)Å and Z = 4. Full-matrix least-squares refinement of the structural parameters led to the following final agreement factors: R₁ (unweighted, based on F) = 0.040 and R₂ (weighted, based on F) = 0.054 for the 2592 independent reflections of the cis isomer having 2θ_MoK¯α <55° and I>3σ₁, and R₁ = 0.033 and R₂ = 0.031 for the 1504 independent reflections of the trans isomer having 2θ_MoK¯α <55° and I>3σ₁. The statistically significant differences that exist between the two isomers for two bond lengths and ten bond angles (p < 0.05) appear to be the direct result of the p-toluyl group orientation with respect to the cyclohexyl and phenyl substituents. In the cis isomer it is anti with respect to the N-cyclohexyl group and cis with respect to the phenyl group, whereas in the trans isomer it is syn with respect to the N-cyclohexyl and trans with respect to the phenyl group. Three-ring to carbonyl hyperconjugation is correlated with stereoelectronic interactions in the trans isomer. Bonding, determined by X-ray and nmr studies, is discussed for the three-membered aziridine ring proper; while bonding, determined by X-ray studies, is discussed for substituents of the aziridine ring. These aziridinyl ketone compounds are of importance as potential mammalian DNA alkylating anti-tumor agents in solid-state solid-state systems. To date only a trans isomer has demonstrated this biological activity in tumor-bearing rats.